We are live on ! Find out more
LPCN icon

Lipocine
LPCN

32 hedge funds and large institutions have $2.12M invested in Lipocine in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

7% more funds holding

Funds holding: 30 → 32 (+2)

0.15% more ownership

Funds ownership: 0.75% → 0.9% (+0.15%)

76% less capital invested

Capital invested by funds: $8.88M → $2.12M (-$6.76M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
5
Closed
7
Calls
–
Puts
$3K
Net Calls
-$3K
Net Calls Change
+$68K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$1.95M
2
BlackRock
BlackRock
New York
+$604K
3
SM
Sabby Management
Florida
+$554K
4
CH
CVI Holdings
Delaware
+$410K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$312K

Top Sellers

1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$404K
2
KCM
Knoll Capital Management
Florida
-$141K
3
QCMA
Quad Capital Management Advisors
New York
-$124K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$111K
5
Ameriprise
Ameriprise
Minnesota
-$110K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$732K +$1.95M +76,029 +212%
Vanguard Group
2
Vanguard Group
Pennsylvania
$353K +$312K +12,171 +29%
BlackRock
3
BlackRock
New York
$298K +$604K +23,574 +107%
Ameriprise
4
Ameriprise
Minnesota
$200K -$110K -4,294 -12%
SM
5
Sabby Management
Florida
$142K +$554K +21,629 New
CH
6
CVI Holdings
Delaware
$105K +$410K +16,027 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$76K +$5.17K +202 +2%
Mercer Global Advisors
8
Mercer Global Advisors
Colorado
$27K -$90.2K -3,521 -46%
CL
9
Choreo LLC
Illinois
$25K – – –
Group One Trading
10
Group One Trading
Illinois
$22K +$80.9K +3,158 +1,161%
Deutsche Bank
11
Deutsche Bank
Germany
$22K +$88.8K +3,468 New
Millennium Management
12
Millennium Management
New York
$20K +$40.7K +1,589 +113%
Northern Trust
13
Northern Trust
Illinois
$19K -$435 -17 -0.6%
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$18K – – –
Hudson Bay Capital Management
15
Hudson Bay Capital Management
Connecticut
$17K +$67.9K +2,651 New
AFM
16
Anson Funds Management
Texas
$8K +$32.2K +1,259 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$5K – – –
CG
18
Cutler Group
California
$5K – – –
State Street
19
State Street
Massachusetts
$5K – – –
OAM
20
Oxford Asset Management
United Kingdom
$5K +$20K +780 New
VF
21
Virtu Financial
New York
$4K +$16.2K +631 New
LTFS
22
Ladenburg Thalmann Financial Services
Florida
$3K +$3.02K +118 +30%
UBS Group
23
UBS Group
Switzerland
$2K +$7.53K +294 +498%
Federated Hermes
24
Federated Hermes
Pennsylvania
$1K -$77 -3 -38%
BFEC
25
Benjamin F. Edwards & Company
Missouri
$1K – – –
1
2

LPCN Hedge Fund Activity: Q4 2019 in Review

32 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q4 2019, worth a combined $2.12M — down 76% from $8.88M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new LPCN positions and 7 closed out — a net gain of 2 holders — while 8 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.95M. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $404K sold.

  • 32 institutional investors held Lipocine (LPCN) as of Q4 2019, up from 30 in Q3 2019.
  • Funds reported $2.12M of Lipocine stock for Q4 2019, down 76% quarter-over-quarter.
  • 9 funds opened new Lipocine positions in Q4 2019 and 7 closed out, a net change of +2 holders.
  • The largest Lipocine buyer in Q4 2019 was Renaissance Technologies, an estimated $1.95M added.
  • The largest Lipocine seller in Q4 2019 was Dimensional Fund Advisors, an estimated $404K sold.

Based on aggregated 13F filings for Q4 2019.